Investing Profile

Frank Yan

InvestorVC
Partner at 3E Bioventures Capital
Photo of Frank Yan, Partner at 3E Bioventures Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
3
CompanyStageDateRound SizeTotal Raised
Myrobalan Therapeutics
Series AJan 2024$24M
$24M
Cullgen
Series BFeb 2021$50M
$50M
Regenacy Pharmaceuticals
Series AMar 2020